Recent research reveals that Kremen2 is upregulated in various tumours, such as renal clear cell carcinoma, breast invasive carcinoma, COAD, and stomach adenocarcinoma, in comparison to that in normal tissues (8). This evidence concerns the gene KREMEN2 and neoplasm.